MROCKI and acute myeloid leukemia: An upregulation of LINC01268 (therein referred as LOC285758) was described also to induce invasion and viability in AML cells by directly sponging miR-204, which inhibited N-Cadherin and TWIST-1 and increased E-Cadherin [53].